EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access

Trastuzumab-Induced Early Corneal Melt in HER2-Positive Breast Cancer: A Case Report and Review

Daniel Barmas-Alamdari, Hasnain Chaudhary, Elmira Baghdasaryan, Prachi Dua, Isha Cheela

American Journal of Case Reports · 2024

DOI: 10.12659/ajcr.945488 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Case Reports, 2024. Verfasst von Daniel Barmas-Alamdari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Northwell Health, New Hyde Park, NY, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Immunological, Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Trastuzumab. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Trastuzumab (Herceptin) is a recombinant DNA-derived humanized monoclonal antibody that the US Food and Drug Administration (FDA) approved in 1998 for metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer therapy. It selectively binds to the extracellular domain of HER2 and mediates an antibody-dependent cellular toxicity in various tissues. Trastuzumab use alone does not typically cause aggressive ocular complications. However, herein is a case report of a patient presenting with corneal ulceration in both eyes and perforation in the left eye after 2 months of trastuzumab therapy. CASE REPORT A 59-year-old woman with a history of metastatic breast cancer receiving chemotherapy was consulted for ophthalmic evaluation. She denied any history of ocular conditions and complained of eyelid crusting and sandy sensation in both eyes for 2 weeks. She had been using antibiotic eyedrops for presumed eye infection before her vision deteriorated 3-4 days prior to presentation. A thorough workup for autoimmune and infectious diseases was unyielding. Ophthalmologic examination revealed multiple epithelial defects with ulceration in the right eye and a corneal ulcer with perforation in the left eye. Corneal cultures were negative. Orbital imaging revealed metastases with optic nerve compression. In conjunction with the oncology team, further trastuzumab treatment was deferred. Therapeutic keratoplasty along with ocular surface therapy eventually stabilized both eyes. CONCLUSIONS Ocular adverse effects such as corneal epithelial changes and melts have been reported with trastuzumab. We recommend ophthalmology consultation for any ocular symptoms in patients on trastuzumab treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, ImmunologicalBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesTrastuzumabFemaleHumansMiddle AgedCorneal PerforationCorneal Ulcer

Substanzen

Antineoplastic Agents, ImmunologicalErb-b2 Receptor Tyrosine KinasesTrastuzumabERBB2 protein, human

Autor:innen und Institutionen

  • Northwell Health, New Hyde Park, NY, USA.
  • Department of Ophthalmology, Manhattan Eye, Ear and Throat Hospital, New York City, NY, USA.
  • Department of Internal Medicine, Staten Island University Hospital, Staten Island, NY, USA.
  • Department of Ophthalmology, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.

Zitieren

APA

Barmas-Alamdari, D., Chaudhary, H., Baghdasaryan, E., Dua, P., & Cheela, I. (2024). Trastuzumab-Induced Early Corneal Melt in HER2-Positive Breast Cancer: A Case Report and Review. American Journal of Case Reports. https://doi.org/10.12659/ajcr.945488

Vancouver

Barmas-Alamdari D, Chaudhary H, Baghdasaryan E, Dua P, Cheela I. Trastuzumab-Induced Early Corneal Melt in HER2-Positive Breast Cancer: A Case Report and Review. American Journal of Case Reports. 2024. doi:10.12659/ajcr.945488

BibTeX
@article{BarmasAlamdari2024,
  author = {Barmas-Alamdari, Daniel and Chaudhary, Hasnain and Baghdasaryan, Elmira and Dua, Prachi and Cheela, Isha},
  title = {Trastuzumab-Induced Early Corneal Melt in HER2-Positive Breast Cancer: A Case Report and Review},
  journal = {American Journal of Case Reports},
  year = {2024},
  doi = {10.12659/ajcr.945488}
}
Kostenlos starten →